Mr. Robert Carl Nygren
Co-Founder & Executive Chairman
Biography unavailable
Decide at what price you'd be comfortable buying and we'll help you stay ready.
PanGenomic Health, Inc. operates as a health care platform company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-07-18. The firm has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support a user's specific health needs. The company has developed a health-tech platform to provide further personal control over mental health treatments. Its personalized insight system helps individuals and healthcare practitioners connect with precision natural remedy mental wellness options. Its mobile application, the Nara App, provides consumers with a knowledge base, which is based on an individual's user profile, developed by tracking treatment regimen and their multidimensional biomarkers (gene, protein, metabolite, microbiota). Its digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to the consumer's Nara App data and their diagnostic reports to improve identification of appropriate natural remedy treatments. Mindleap Health Inc. is its subsidiary.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more